UnitedHealth Group Incorporated (NYSE:UNH) – Stock analysts at Cantor Fitzgerald boosted their FY2017 EPS estimates for shares of UnitedHealth Group in a report released on Wednesday. Cantor Fitzgerald analyst S. Halper now anticipates that the healthcare conglomerate will post earnings of $10.00 per share for the year, up from their previous estimate of $9.82. Cantor Fitzgerald currently has a “Overweight” rating and a $225.00 target price on the stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2018 earnings at $10.85 EPS.

A number of other research firms have also commented on UNH. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. BidaskClub raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 8th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 28th. Bank of America Corporation raised their price target on shares of UnitedHealth Group from $210.00 to $214.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. Finally, Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $215.27.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-to-post-fy2017-earnings-of-10-00-per-share-cantor-fitzgerald-forecasts/1645156.html.

UnitedHealth Group (NYSE UNH) opened at 207.49 on Friday. The company has a market cap of $205.21 billion, a P/E ratio of 23.56 and a beta of 0.63. UnitedHealth Group has a one year low of $133.03 and a one year high of $208.21. The company has a 50-day moving average of $197.42 and a 200 day moving average of $185.93.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.17 EPS.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 77,149 shares of company stock worth $15,182,242. 0.89% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Regal Wealth Group Inc. boosted its position in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its position in UnitedHealth Group by 0.4% during the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares during the period. RB Capital Management LLC boosted its position in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Altfest L J & Co. Inc. boosted its position in UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after buying an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust boosted its position in UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. Institutional investors own 86.11% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.